Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity. (Q50094012)
Jump to navigation
Jump to search
scientific article published in March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity. |
scientific article published in March 2006 |
Statements
1 reference
Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity. (English)
1 reference
Hiroyuki Mizuguchi
1 reference
Naoya Koizumi
1 reference
Kenji Kawabata
1 reference
Fuminori Sakurai
1 reference
Yoshiteru Watanabe
1 reference
Takao Hayakawa
1 reference
1 March 2006
1 reference
1 reference
17
1 reference
3
1 reference
264-279
1 reference
Identifiers
1 reference
1 reference